Loading...
Skip to content
get in touch

Lay Information

We are skilled at writing plain language information for a lay audience, including patients and patient advocates

HTAi Summary of Information for Patients (SIP)

We are skilled and highly proficient at translating clinical, health economic and humanistic (PRO) information into content that can be understood by a lay audience. We are able to support pharmaceutical companies in writing their HTAi Summary of Information for Patients (SIP) documents, and work with health literacy agencies to seek plain language accreditation.

$375bnexpected spending total on cancer medicines by 2027
5%global increase number of treated patients over the past five years
2,000oncology products currently under development

a consultancy you can trust

we are 

industry experts
we are
dedicated
we are
patient-centric

a wealth of life science
knowledge and expertise

Oncology Access Solutions Ltd is led and founded by Dr Clare Hague – a highly experienced health economist and health services researcher with a strong industry and academic background.

With over 18 years of industry experience with large, mid-sized and start-up biotech companies, we Clare is a seasoned and knowledgeable independent consultant able to provide a discreet and dedicated service.

Learn more

explore our services

Advisory BoardsAdvisory BoardsProvision of expert advice to companies
Learn more
Capability BuildingCapability BuildingBe-spoke technical and leadership training of market access teams
Learn more
Lay InformationLay InformationPlain language information for a lay audience, including patients and patient advocates
Learn more
Market Access and Evidence Generation StrategiesMarket Access and Evidence Generation StrategiesDevelopment of market access strategies
Learn more
Scientific Advice Scientific Advice Development and/or expert review of HTA Scientific Advice
Learn more
TPPs & TPCsTPPs & TPCsTarget Product Profiles & Target Product Claims
Learn more